Prophylaxis News and Research

RSS

Europe reports the highest ever levels of syphilis

A new study on syphilis has revealed the horrifying truth that more men than ever are contracting the sexually transmitted infection (STI) syphilis in Europe. The most heavily infected group comprises men having sex with men (MSM). At present, syphilis affects more people than HIV in the European Union.

15 Jul 2019

Scripps CHAVD wins $129 million NIH grant to advance new HIV vaccine approach

The Scripps Consortium for HIV/AIDS Vaccine Development, an international collaboration led by Scripps Research, has received a $129 million grant from the National Institutes of Health to advance next-generation vaccines designed to coax the immune system into producing antibodies capable of disarming numerous strains of HIV.

11 Jul 2019

Novel method can help clinicians identify individuals most in need of PrEP

Researchers have demonstrated the effectiveness of using algorithms that analyze electronic health records to help physicians identify patients at risk for HIV who may benefit from preexposure prophylaxis, which significantly reduces the risk of getting HIV.

9 Jul 2019

Two new studies develop algorithms to identify patients at risk of acquiring HIV

Two new studies developed algorithms that can identify patients who are at risk of acquiring HIV and may benefit from preventive care. Both studies appear in the July 5 issue of The Lancet HIV.

8 Jul 2019

Study emphasizes need for better education to improve health care for LGBTQ

A first-of-its-kind survey of American neurologists reveals that more than half carry the mistaken belief that a patient's sexual orientation and gender identity have no bearing on treatment of neurologic illness.

18 Jun 2019

Long-acting contraceptives do not increase risk of HIV, concludes new study

One of the largest and most robust studies on HIV infection rates has concluded that long-acting contraceptives do not increase the risk of contracting HIV.

14 Jun 2019

AMA adopts new policies aimed at improving health of the nation

The American Medical Association, the premier national physician organization in the country, voted this week to adopt new policies aimed at improving the health of the nation.

14 Jun 2019

More screening and new treatments needed for sickle cell disease

The promise of new treatments for sickle cell disease, a group of inherited red blood cell disorders, has never been so great, but it will only be realized if there is constant investment in health policies such as programs for screening newborns, especially in sub-Saharan Africa, where most cases occur.

13 Jun 2019

Study: 81% of antibiotics prescribed by dentists to prevent infections are unnecessary

A new study conducted by researchers at the University of Illinois at Chicago and published in JAMA Network Open has found that 81% of antibiotics prescribed by dentists - who are among the top prescribers in the U.S., accounting for about 10% of all antibiotic prescriptions - to prevent infections prior to dental visits are unnecessary.

31 May 2019

HIV prevention pill may be cost-effective way of curbing the epidemic in India

Pre-exposure prophylaxis, a combination drug used to prevent HIV infection, has already gained significant traction in the U.S. and Europe.

10 May 2019

Better training needed for internal medicine residents to combat HIV epidemic, survey suggests

The nation's HIV epidemic remains stubbornly persistent, with almost 40,000 new infections annually in the United States.

8 May 2019

Key research takeaways from ECCMID 2019

This article aims to provide a brief overview of the key themes of the 29th ECCMID conference and update readers on current research projects.

From ESCMID 19 Apr 2019

Coagulation factor VIIa prevents bleeds in hemophilia animal models

Hematology researchers have further refined how a treatment currently used on an urgent basis to control bleeding in hemophilia patients holds promise as a preventive treatment as well.

16 Apr 2019

Latest anti-retroviral drug therapies offer powerful solution for HIV infection-associated frailty

Treatment of the HIV/AIDS epidemic has seen remarkable advancements with the advent of the latest anti-retroviral drug therapy and powerful tools to test for drug resistance, making the infection almost "undetectable" in patients who strictly comply with their medication therapy, a just-published perspective article by a clinical team at the University of Arizona College of Medicine - Tucson points out.

27 Feb 2019

Study: New HIV infections could be reduced by up to 67% in the next decade

New HIV infections in the United States could be substantially reduced by up to 67 percent by 2030 if ambitious goals for HIV care and treatment are met and targeted prevention interventions for people at risk for HIV are rapidly scaled up, according to a study by Georgia State University and the University at Albany-SUNY.

23 Feb 2019

New clinical trial aims to examine safety and use of two HIV prevention tools

A clinical trial has begun to examine the safety and use of two HIV prevention tools--oral pre-exposure prophylaxis and a vaginal ring--in adolescent girls and young women in southern Africa.

8 Feb 2019

MTN launches new study to empower teen girls with choices in HIV prevention

AIDS is already the leading cause of death among girls and young women in much of Africa, and matters could only get worse, given that for every day that passes, 1,000 more girls ages 15 to 24 are likely to become infected with HIV.

8 Feb 2019

Advantages of universal GBS screening for pregnant women unclear

Serological group B streptococci are common bacteria, which usually remain unnoticed. This is also the case for the almost 20% of pregnant women with vaginal or anal colonization of GBS.

5 Feb 2019

Drought in rural Lesotho increases HIV risk among adolescent girls

Adolescent girls exposed to severe drought conditions in rural Lesotho had higher rates of HIV, according to a new study led by researchers at ICAP at Columbia University, a global health organization based at the Columbia Mailman School of Public Health, and from the Lesotho Ministry of Health and U.S. Centers for Disease Control and Prevention.

25 Jan 2019

New drug for treating liver parasites in vivax malaria

Vivax malaria is a serious illness with high fever that, if untreated, can keep people bed-ridden for weeks or even months. But even after successful treatment, it's tricky: although the current, commonly-used drugs successfully treat the blood stage of vivax malaria, they are unable to prevent malaria parasites from invading the liver (liver stage) and causing the disease to recur repeatedly over many years.

21 Jan 2019